AzTrials
AzTrials

Gay MenNCT07369661

A Brief Self-compassion Intervention for Body Image, Minority Stress, and Sexual Self-efficacy in Hong Kong Gay Men

A study testing Brief self-compassion intervention in people with Gay Men, run by Hong Kong Metropolitan University at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pilot study aims to explore the feasibility, acceptability, and preliminary effectiveness of a brief self-compassion writing intervention on body image, minority stress, and sexual self-efficacy among gay men in Hong Kong. Read more about this study

Who is it for?
Ages 18 years and older, men only
Conditions the study is for
Gay Men
What is being tested?
Brief self-compassion intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteHong Kong
Study dates
27 Apr 2026to 28 Aug 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • aged 18 years or above
  • self-identified as a gay man
  • sufficient comprehension of Cantonese
  • currently living in Hong Kong
  • able to provide informed consent

Who cannot join

  • currently experiencing psychosis
  • having an intellectual disability
  • experiencing current suicidal ideation
  • not currently receiving or engaging in regular mental health services in the last 3 months
  • participation in a similar study or receiving similar services in the past 12 months

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Hong Kong Metropolitan University

    Hong Kong

Other trials in Hong Kong

About this study

This pilot study aims to explore the feasibility, acceptability, and preliminary effectiveness of a brief self-compassion writing intervention on body image, minority stress, and sexual self-efficacy among gay men in Hong Kong.

Read the detailed description

Gay men experience greater body dissatisfaction, a stronger drive for muscularity, and heightened body image concerns compared to their heterosexual counterparts. These issues contribute to minority stress, anxiety, low self-esteem, and engagement in risky sexual behaviors. Using a randomized controlled trial (RCT) design, we aim to explore the feasibility, acceptability, and preliminary effectiveness of a brief self-compassion writing intervention on body image, minority stress, and sexual self-efficacy among gay men in Hong Kong.

Conditions
Gay Men
Being tested
Brief self-compassion intervention
Keywords
gay men, self-compassion, body image, mental health
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief self-compassion interventionBehavioural

    Participants will be randomly allocated to the self-compassion group and the waiting list control group. The interveintion group will receive a 2.5 self-compassion training, and 3 week self-compassion writing exercise.

Study groups in NCT07369661
Study groupRoleWhat they receive
Self-compassion interventional groupExperimentalInterventional group will include 2.5 hour training and 3 weeks self-compassion writing exercise
Receives: Behavioral: Brief self-compassion intervention
Waiting-list control groupNo interventionWaiting-list control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. self-compassion

    Self-compassion will be measured using the 12-item short version of the self-compassion scale (SCS). Items are rated on a 5-point Likert scale ranging from 1 (Almost Never) to 5 (Almost Always). The total score ranged from 12 to 60, with higher score indicating higher level of self-compassion.

    Measured: From enrollment to the end of intervention at 1 month

Secondary outcomes (8)
  1. Sexuality-based stigma

    Sexuality-based stigma will be measured by the 10-item Chinese men sex with men (MSM) Stigma Scale. Items are rated on a four-point Likert scale from 1 (never) to 4 (many times). The total score ranges from 10 to 40, with higher score indicating higher level of sexuality-based stigma.

    Measured: From enrollment to the end of treatment at 1 month

  2. Internalized stigma

    Internalized stigma will be measured with the 5-item revised internalized homophobia scale (IHP-R). Items are measured on a five-point Likert scale between 1 (Strongly Disagree) and 5 (Strongly Agree). The total score ranges from 5 to 25, with higher scores indicate greater internalized stigma.

    Measured: From enrollment to the end of treatment at 1 month

  3. anxiety

    Anxiety symptoms will be measured using the 7-item Generalized Anxiety Disorder-7 (GAD-7). Items are rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 21, with higher total scores indicating higher levels of anxiety symptoms

    Measured: From enrollment to the end of treatment at 1 month

  4. self-esteem

    The 10-item Rosenberg Self-Esteem Scale (RSE) will be used to measured self-esteem. Items will be rated on a 4-point Liker scale (1 = Strongly agree, 4 = Strongly disagree). The total score ranges from 10 to 40, with higher score indicating higher level of self-esteem.

    Measured: From enrollment to the end of treatment at 1 month

  5. body objectification

    Self-objectification will be measured using the Chinese version of the Objectified Body Consciousness Scale (OBCS) - body-surveillance subscale. It consists of eight items rated on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree). The total score ranges from 7 to 56, with a higher score indicating a higher level of body surveillance.

    Measured: From enrollment to the end of treatment at 1 month

  6. sexual self-efficacy

    The 14-item Condom Self-Efficacy Scale (CSES) will be used to measurement participants' sexual self-efficacy. Items will be measured on a 5-point Likert scale, ranging from 1 (very unsure) to 5 (very sure). The total score ranging from 14 to 70, with higher scores indicated a higher level of condom use efficacy.

    Measured: From enrollment to the end of treatment at 1 month

  7. Body shame

    Body shame will be measured using the Chinese version of the Objectified Body Consciousness Scale (OBCS) - body shame subscale (McKinley \& Hyde, 1996). It consists of six items rated on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree), with a higher score indicating a higher level of body shame.

    Measured: From enrollment to the end of intervention at 1 month

  8. Depression

    Depression will be measured using the Chinese version of the 9-item Patient Health Questionnaire (PHQ-9). Items are rated on a 4-point Likert scale ranging from 0 (not at all) to 3 (nearly every day). The total score ranges from 0 to 27, with higher total scores indicating higher levels of depressive symptoms.

    Measured: From enrollment to the end of intervention at 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2026
  2. Study start27 Apr 2026
  3. Primary completion28 Jul 2026
  4. Study completion28 Aug 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
We will include a self-compassion intervention group and a waiting-list control group.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07369661
Sponsor's protocol ID
HE-NHS2025/05
Other IDs
M2025/06
Status last verified
Aug 2026
First submitted
18 Jan 2026
Last updated
31 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Brief self-compassion intervention in people with Gay Men, run by Hong Kong Metropolitan University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

self-compassion (time frame: From enrollment to the end of intervention at 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in